Literature DB >> 31814920

LncRNA PTCSC3 suppressed cervical carcinoma cell invasion and proliferation via regulating miR-574-5p.

Min Zhang1, Yinghui Song1, Lijuan Yu1.   

Abstract

LncRNAs have been shown to invovled in the development of various cancers. However, the function and potential mechanism of PTCSC3 in cervical carcinoma progression remains unknown. In this reference, we showed that PTCSC3 expression was downregulated in 4 cervical carcinoma cell lines (Caski, Siha, Hela and C4-1) compared to control cell line (GH329). Expression of PTCSC3 was downregulated in cervical carcinoma samples compared to non-cancerous samples. Ectopic expression of PTCSC3 inhibited miR-574-5p expression and enhanced the expression of SCAI both in Hela cell and Siha cell. We proved that the miR-574-5p expression was overexpressed in 4 cervical carcinoma cell lines (Caski, Siha, Hela and C4-1) compared to control cell line (GH329). Expression of miR-574-5p was overexpressed in cervical carcinoma samples compared to non-cancerous samples. Furthermore, we indicated that expression of miR-574-5p was negatively correlated with expression of PTCSC3 in cervical carcinoma. Ectopic expression of PTCSC3 decreased cell proliferation and invasion. Finally, we indicated that PTCSC3 overexpression suppressed cervical carcinoma progression via regulating miR-574-5p expression. These data suggested that PTCSC3 played as an oncogene in progression of cervical carcinoma. AJTR
Copyright © 2019.

Entities:  

Keywords:  Cervical carcinoma; PTCSC3; lncRNA; miR-574-5p

Year:  2019        PMID: 31814920      PMCID: PMC6895514     

Source DB:  PubMed          Journal:  Am J Transl Res        ISSN: 1943-8141            Impact factor:   4.060


  43 in total

1.  miR-506 acts as a tumor suppressor by directly targeting the hedgehog pathway transcription factor Gli3 in human cervical cancer.

Authors:  S-Y Wen; Y Lin; Y-Q Yu; S-J Cao; R Zhang; X-M Yang; J Li; Y-L Zhang; Y-H Wang; M-Z Ma; W-W Sun; X-L Lou; J-H Wang; Y-C Teng; Z-G Zhang
Journal:  Oncogene       Date:  2014-03-10       Impact factor: 9.867

2.  Long non-coding RNA CRNDE sponges miR-384 to promote proliferation and metastasis of pancreatic cancer cells through upregulating IRS1.

Authors:  Gang Wang; Jingen Pan; Lu Zhang; Yajun Wei; Cheng Wang
Journal:  Cell Prolif       Date:  2017-09-21       Impact factor: 6.831

3.  LncRNA-MEG3 inhibits cell proliferation of endometrial carcinoma by repressing Notch signaling.

Authors:  Qingyun Guo; Zhida Qian; Dingding Yan; Li Li; Lili Huang
Journal:  Biomed Pharmacother       Date:  2016-06-08       Impact factor: 6.529

4.  lncRNA CCAT1 Promotes Glioma Tumorigenesis by Sponging miR-181b.

Authors:  Bingzhou Cui; Baoshan Li; Qi Liu; Youqiang Cui
Journal:  J Cell Biochem       Date:  2017-05-31       Impact factor: 4.429

5.  LncRNA PVT1 overexpression is a poor prognostic biomarker and regulates migration and invasion in small cell lung cancer.

Authors:  Chengsuo Huang; Shuguang Liu; Huijun Wang; Zicheng Zhang; Qing Yang; Fang Gao
Journal:  Am J Transl Res       Date:  2016-11-15       Impact factor: 4.060

6.  Long noncoding RNA CRNDE activates Wnt/β-catenin signaling pathway through acting as a molecular sponge of microRNA-136 in human breast cancer.

Authors:  Jinliang Huan; Li Xing; Qianhuang Lin; Hu Xui; Xianju Qin
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

7.  The lncRNA n340790 accelerates carcinogenesis of thyroid cancer by regulating miR-1254.

Authors:  Qinghuai Li; Wei Shen; Xiaoyu Li; Linlei Zhang; Xiao Jin
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

8.  LncRNA-RP11-296A18.3/miR-138/HIF1A Pathway Regulates the Proliferation ECM Synthesis of Human Nucleus Pulposus Cells (HNPCs).

Authors:  Xiaobin Wang; Guohua Lv; Jing Li; Bing Wang; Qianshi Zhang; Chang Lu
Journal:  J Cell Biochem       Date:  2017-06-19       Impact factor: 4.429

9.  MiR-181a confers resistance of cervical cancer to radiation therapy through targeting the pro-apoptotic PRKCD gene.

Authors:  G Ke; L Liang; J M Yang; X Huang; D Han; S Huang; Y Zhao; R Zha; X He; X Wu
Journal:  Oncogene       Date:  2012-07-30       Impact factor: 9.867

10.  A long non-coding RNA, PTCSC3, as a tumor suppressor and a target of miRNAs in thyroid cancer cells.

Authors:  Min Fan; Xinying Li; Wei Jiang; Yun Huang; Jingdong Li; Zhiming Wang
Journal:  Exp Ther Med       Date:  2013-01-30       Impact factor: 2.447

View more
  7 in total

1.  LncRNA PTCSC3 and lncRNA HULC Negatively Affect Each Other to Regulate Cancer Cell Invasion and Migration in Gastric Cancer.

Authors:  Yi Cai; Yang Li; Bin Sun; Hugen Wang; Weiping Zhang; Yuanyuan Zhao; Haodong Zhao; Jianlin Zhang; Jianming Xu; Yalei Wang
Journal:  Cancer Manag Res       Date:  2020-09-16       Impact factor: 3.989

2.  hsa_circ_0008234 inhibits the progression of lung adenocarcinoma by sponging miR-574-5p.

Authors:  Wei Jiang; Yaozhou He; Zijian Ma; Yu Zhang; Chengpeng Zhang; Nianpeng Zheng; Xing Tang
Journal:  Cell Death Discov       Date:  2021-05-28

3.  The Search of miRNA Related to Invasive Growth of Nonfunctioning Gonadotropic Pituitary Tumors.

Authors:  Joanna Boresowicz; Paulina Kober; Natalia Rusetska; Maria Maksymowicz; Agnieszka Paziewska; Michalina Dąbrowska; Natalia Zeber-Lubecka; Jacek Kunicki; Wiesław Bonicki; Jerzy Ostrowski; Janusz A Siedlecki; Mateusz Bujko
Journal:  Int J Endocrinol       Date:  2020-12-05       Impact factor: 3.257

4.  Serum-derived miR-574-5p-containing exosomes contribute to liver fibrosis by activating hepatic stellate cells.

Authors:  Xia Zhou; Ziyu Liang; Shanyu Qin; Xianxian Ruan; Haixing Jiang
Journal:  Mol Biol Rep       Date:  2021-11-29       Impact factor: 2.316

5.  LncRNA MALAT1 Accelerates Cervical Carcinoma Proliferation by Suppressing miR-124 Expression in Cervical Tumor Cells.

Authors:  Tian Liang; Yuchen Wang; Yu Jiao; Shanshan Cong; Xinyan Jiang; Lina Dong; Guangmei Zhang; Dan Xiao
Journal:  J Oncol       Date:  2021-06-15       Impact factor: 4.375

6.  ELFN1-AS1 accelerates cell proliferation, invasion and migration via regulating miR-497-3p/CLDN4 axis in ovarian cancer.

Authors:  Youkun Jie; Lu Ye; He Chen; Xiaohong Yu; Li Cai; Wenfeng He; Yonghui Fu
Journal:  Bioengineered       Date:  2020-12       Impact factor: 3.269

7.  miR-378a-5p improved the prognosis and suppressed the progression of hepatocellular carcinoma by targeting the VEGF pathway.

Authors:  Haibo Zou; Lan Yang
Journal:  Transl Cancer Res       Date:  2020-03       Impact factor: 1.241

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.